Cibc World Markets Corp Vertex Pharmaceuticals Inc Transaction History

Cibc World Markets Corp

  • $14.8 Billion
  • Q2 2025

A detailed history of Cibc World Markets Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Cibc World Markets Corp holds 50,606 shares of VRTX stock, worth $22 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
50,606
Previous 31,007 63.21%
Holding current value
$22 Million
Previous $15 Million 49.87%
% of portfolio
0.15%
Previous 0.12%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$421.16 - $509.5 $8.25 Million - $9.99 Million
19,599 Added 63.21%
50,606 $22.5 Million
Q1 2025

May 13, 2025
SELL
$402.49 - $513.76 $6.17 Million - $7.88 Million
-15,332 Reduced 33.09%
31,007 $15 Million
Q4 2024

Feb 10, 2025
BUY
$396.64 - $516.74 $2.25 Million - $2.93 Million
5,665 Added 13.93%
46,339 $18.7 Million
Q3 2024

Nov 13, 2024
SELL
$460.0 - $505.78 $5.18 Million - $5.69 Million
-11,254 Reduced 21.67%
40,674 $18.9 Million
Q2 2024

Aug 12, 2024
BUY
$392.81 - $485.53 $3.56 Million - $4.4 Million
9,069 Added 21.16%
51,928 $24.3 Million
Q1 2024

May 13, 2024
SELL
$407.69 - $446.08 $19.8 Million - $21.7 Million
-48,560 Reduced 53.12%
42,859 $17.9 Million
Q4 2023

Feb 13, 2024
BUY
$343.0 - $410.68 $16.3 Million - $19.5 Million
47,483 Added 108.07%
91,419 $37.2 Million
Q3 2023

Nov 13, 2023
SELL
$338.18 - $362.46 $2.64 Million - $2.83 Million
-7,821 Reduced 15.11%
43,936 $15.3 Million
Q2 2023

Aug 04, 2023
BUY
$314.42 - $351.91 $11.2 Million - $12.6 Million
35,671 Added 221.75%
51,757 $18.2 Million
Q1 2023

May 11, 2023
SELL
$283.23 - $323.1 $4.86 Million - $5.54 Million
-17,144 Reduced 51.59%
16,086 $5.07 Million
Q4 2022

Feb 09, 2023
BUY
$285.76 - $321.48 $8.38 Million - $9.43 Million
29,339 Added 754.02%
33,230 $9.6 Million
Q3 2022

Nov 14, 2022
SELL
$273.83 - $305.53 $7.73 Million - $8.62 Million
-28,220 Reduced 87.88%
3,891 $1.13 Million
Q2 2022

Aug 12, 2022
SELL
$234.96 - $292.55 $6.49 Million - $8.08 Million
-27,629 Reduced 46.25%
32,111 $9.05 Million
Q1 2022

May 13, 2022
BUY
$221.42 - $260.97 $13.2 Million - $15.6 Million
59,740 New
59,740 $15.6 Million
Q4 2021

Feb 11, 2022
SELL
$177.01 - $223.45 $12.2 Million - $15.4 Million
-68,765 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$181.39 - $202.99 $8.7 Million - $9.74 Million
47,986 Added 230.94%
68,765 $12.5 Million
Q2 2021

Aug 10, 2021
SELL
$187.49 - $221.1 $20.8 Million - $24.5 Million
-110,750 Reduced 84.2%
20,779 $4.19 Million
Q1 2021

May 07, 2021
BUY
$207.02 - $241.31 $12.5 Million - $14.6 Million
60,367 Added 84.83%
131,529 $28.3 Million
Q4 2020

Feb 12, 2021
BUY
$207.01 - $276.09 $5.24 Million - $6.98 Million
25,297 Added 55.16%
71,162 $16.8 Million
Q3 2020

Nov 12, 2020
BUY
$255.65 - $303.1 $932,611 - $1.11 Million
3,648 Added 8.64%
45,865 $12.5 Million
Q2 2020

Aug 12, 2020
SELL
$225.48 - $295.8 $6.89 Million - $9.04 Million
-30,555 Reduced 41.99%
42,217 $12.3 Million
Q1 2020

May 12, 2020
BUY
$199.77 - $247.81 $4.27 Million - $5.3 Million
21,379 Added 41.6%
72,772 $17.3 Million
Q4 2019

Feb 13, 2020
SELL
$166.71 - $223.91 $8.37 Million - $11.2 Million
-50,204 Reduced 49.41%
51,393 $11.3 Million
Q3 2019

Nov 12, 2019
BUY
$166.23 - $187.09 $7.16 Million - $8.06 Million
43,073 Added 73.6%
101,597 $17.2 Million
Q2 2019

Aug 13, 2019
SELL
$164.61 - $190.37 $440,167 - $509,049
-2,674 Reduced 4.37%
58,524 $10.7 Million
Q1 2019

May 14, 2019
SELL
$163.73 - $194.7 $14.7 Million - $17.4 Million
-89,538 Reduced 59.4%
61,198 $11.3 Million
Q4 2018

Feb 13, 2019
BUY
$151.91 - $192.21 $11.2 Million - $14.2 Million
73,901 Added 96.18%
150,736 $25 Million
Q3 2018

Nov 13, 2018
BUY
$167.73 - $192.74 $3.39 Million - $3.89 Million
20,202 Added 35.67%
76,835 $14.8 Million
Q2 2018

Aug 13, 2018
BUY
$145.72 - $169.96 $1.39 Million - $1.63 Million
9,571 Added 20.34%
56,633 $9.63 Million
Q1 2018

May 11, 2018
SELL
$151.6 - $177.13 $4.25 Million - $4.97 Million
-28,065 Reduced 37.36%
47,062 $7.67 Million
Q4 2017

Feb 13, 2018
BUY
$137.28 - $155.55 $2.42 Million - $2.74 Million
17,596 Added 30.59%
75,127 $11.3 Million
Q3 2017

Nov 14, 2017
BUY
$148.13 - $162.24 $8.52 Million - $9.33 Million
57,531
57,531 $8.75 Million

Others Institutions Holding VRTX

# of Institutions
1,787
Shares Held
231M
Call Options Held
1.83M
Put Options Held
1.21M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $111B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Cibc World Markets Corp Portfolio

Follow Cibc World Markets Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email